(UIMR) UBS(Lux)Fund Solutions – - Ratings and Ratios
European Stocks, Equity Funds, UCITS ETF, Eurozone Stocks
Description: UIMR UBS(Lux)Fund Solutions –
The UBS(Lux)Fund Solutions – MSCI EMU Socially Responsible UCITS ETF(EUR)A-dis EUR is an exchange-traded fund (ETF) that tracks the Morningstar Developed Europe ex Eurozone TME NR EUR Index, focusing on Eurozone large-cap equity with a socially responsible investing (SRI) approach. As of the latest data, the fund has a significant presence in the market with a substantial Assets Under Management (AUM) of 816.05 million EUR.
From a technical analysis perspective, the ETFs price is currently at 130.88 EUR, slightly below its short-term moving averages (SMA20 at 131.83 and SMA50 at 131.52), indicating a potential short-term bearish trend or consolidation phase. However, being above its SMA200 at 125.34 suggests an overall long-term bullish trend. The Average True Range (ATR) is 0.95, translating to a volatility of 0.73%, which is relatively moderate. The ETF has reached a 52-week high of 135.38 and a low of 110.59, showing its resilience and the overall market condition.
To further analyze the ETFs performance, key performance indicators (KPIs) such as the expense ratio, tracking error, and dividend yield could be examined. Typically, for an ETF like UIMR, a lower expense ratio is desirable as it directly impacts the net returns to investors. The tracking error, which measures how closely the ETF follows its underlying index, is also crucial. A lower tracking error indicates a more accurate replication of the indexs performance. Additionally, the dividend yield, which is a portion of the funds income distributed to shareholders, can be an attractive feature for income-seeking investors.
Given its SRI focus, the ETF is likely to exclude companies that do not meet certain environmental, social, and governance (ESG) criteria. This could potentially lead to a different performance profile compared to a non-SRI ETF tracking a similar index. Investors should evaluate whether the SRI criteria align with their investment goals and values. Moreover, the ETFs adherence to UCITS (Undertakings for Collective Investment in Transferable Securities) regulations ensures a certain level of regulatory compliance and investor protection, making it a viable option for a wide range of investors.
Additional Sources for UIMR ETF
UIMR ETF Overview
Market Cap in USD | 953m |
Category | Eurozone Large-Cap Equity |
TER | 0.20% |
IPO / Inception | 2011-08-18 |
UIMR ETF Ratings
Growth Rating | 63.6 |
Fundamental | - |
Dividend Rating | 40.5 |
Rel. Strength | -0.87 |
Analysts | - |
Fair Price Momentum | 126.19 EUR |
Fair Price DCF | - |
UIMR Dividends
Dividend Yield 12m | 1.95% |
Yield on Cost 5y | 2.86% |
Annual Growth 5y | 5.92% |
Payout Consistency | 93.6% |
Payout Ratio | % |
UIMR Growth Ratios
Growth Correlation 3m | 35.9% |
Growth Correlation 12m | 84.7% |
Growth Correlation 5y | 73.5% |
CAGR 5y | 8.98% |
CAGR/Max DD 5y | 0.34 |
Sharpe Ratio 12m | 1.28 |
Alpha | 4.65 |
Beta | 0.569 |
Volatility | 11.21% |
Current Volume | 1k |
Average Volume 20d | 0.2k |
Stop Loss | 127.5 (-3.5%) |
As of July 14, 2025, the stock is trading at EUR 132.08 with a total of 952 shares traded.
Over the past week, the price has changed by +0.30%, over one month by +0.69%, over three months by +9.25% and over the past year by +12.19%.
Yes. Based on ValueRay's Analyses, UBS(Lux)Fund Solutions – (AS:UIMR) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 63.58 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of UIMR is around 126.19 EUR . This means that UIMR is currently overvalued and has a potential downside of -4.46%.
UBS(Lux)Fund Solutions – has no consensus analysts rating.
According to our own proprietary Forecast Model, UIMR UBS(Lux)Fund Solutions – will be worth about 142.6 in July 2026. The stock is currently trading at 132.08. This means that the stock has a potential upside of +8%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 142.6 | 8% |